ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, announced that it will present at the 15th Annual BIO CEO & Investor Conference on Tuesday, February 12, 2013, at 10:00 a.m. Eastern Time at The Waldorf=Astoria Hotel in New York City.
